NGD-4715 is a selective and orally active melanin-concentrating hormone receptor 1 (MCHR1) antagonist .
NGD-4715 was developed for the treatment of obesity. The research has been discontinued[1].
NGD-4715 is a selective and orally active melanin-concentrating hormone receptor 1 (MCHR1) antagonist .
NGD-4715 was developed for the treatment of obesity. The research has been discontinued[1].